Molecular analysis of IDH1/2 mutations and MGMT promoter methylation in gliomas and meningiomas

被引：0
|
作者：
Saetta, A. [1 ]
Gioti, A. [1 ]
Chatziandreou, I. [1 ]
Tsioli, P. [1 ]
Soldatos, R. F. [1 ]
Sakellariou, S. [1 ]
Samaras, V. [1 ]
Sepsa, A. [1 ]
Zisakis, A. [1 ]
Korkolopoulou, P. [1 ]
Patsouris, E. [1 ]
机构：
[1] Univ Athens, Dept Pathol 1, GR-10679 Athens, Greece
来源：
VIRCHOWS ARCHIV | 2013年 / 463卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：319 / 319
页数：1
相关论文
共 50 条
  • [21] Favorable role of IDH1/2 mutations aided with MGMT promoter gene methylation in the outcome of patients with malignant glioma
    Pandith, Arshad A.
    Qasim, Iqbal
    Baba, Shahid M.
    Koul, Aabid
    Zahoor, Wani
    Afroze, Dil
    Lateef, Adil
    Manzoor, Usma
    Bhat, Ina A.
    Sanadhya, Dheera
    Bhat, Abdul R.
    Ramzan, Altaf U.
    Mohammad, Fozia
    Anwar, Iqra
    FUTURE SCIENCE OA, 2021, 7 (03):
  • [22] IDH1 AND IDH2 MUTATIONS AND THEIR CORRELATIONS IN GLIOMAS
    Mellai, M.
    Monzeglio, O.
    Piazzi, A.
    Giordano, M.
    Andreoli, E.
    Cassoni, P.
    Schiffer, D.
    NEURO-ONCOLOGY, 2010, 12 : 32 - 32
  • [23] Targeting IDH1/IDH2 mutations in gliomas
    de la Fuente, Macarena I.
    CURRENT OPINION IN NEUROLOGY, 2022, 35 (06) : 787 - 793
  • [24] TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations
    Kim, Young-Ho
    Pierscianek, Daniela
    Mittelbronn, Michel
    Vital, Anne
    Mariani, Luigi
    Hasselblatt, Martin
    Ohgaki, Hiroko
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (10) : 850 - 852
  • [25] IDH1 and IDH2 Mutations in Gliomas REPLY
    Reitman, Zachary
    Yan, Hai
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (21): : 2249 - 2249
  • [26] Association of IDH1 Mutation and MGMT Promoter Methylation with Clinicopathological Parameters in an Ethnically Diverse Population of Adults with Gliomas in England
    Wanis, Hiba A.
    Moller, Henrik
    Ashkan, Keyoumars
    Davies, Elizabeth A.
    BIOMEDICINES, 2024, 12 (12)
  • [27] Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813
    Fleming, J. L.
    Pugh, S.
    Bell, E. H.
    Chang, S. M.
    McElroy, J.
    Becker, A.
    Timmers, C. D.
    Shih, H. A.
    Ashby, L.
    Hunter, G. K.
    Bahary, J. P.
    Schultz, C. J.
    Kavanagh, B. D.
    Yung, W. A.
    Robins, I.
    Werner-Wasik, M.
    Chakravarti, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (05): : 1399 - 1399
  • [28] Frequency of MGMT Promoter Hypermethylation, 1p/19q Co-Deletions and IDH1 and IDH2 Mutations in Gliomas
    Shajani-Yi, Z.
    Nguyen, L. N.
    Hickey, W. F.
    Deharvengt, S. J.
    de Abreu, F. Blumental
    Peterson, J. D.
    Gallagher, T. L.
    Erskine, A. J.
    Lefferts, J. A.
    Tsongalis, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 1023 - 1023
  • [29] PEDIATRIC GLIOMAS. ANALYSIS OF IDH1 MUTATIONS
    Sunol, Mariona
    Ribalta, Teresa
    Cruz, Ofelia
    Cusi, Victoria
    Rovira, Carlota
    Jou, Cristina
    Galvan, Patricia
    Rodriguez, Eva
    de Torres, Carmen
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1087 - 1087
  • [30] The clinical use of IDH1 and IDH2 mutations in gliomas
    Picca, Alberto
    Berzero, Giulia
    Di Stefano, Anna Luisa
    Sanson, Marc
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (12) : 1041 - 1051
12345